专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US08060086B1 Method and apparatus for processing mobile-IP registration requests 有权
标题翻译：用于处理移动IP注册请求的方法和装置
公开(公告)号：US08060086B1
公开(公告)日：2011-11-15
申请号：US11934408
申请日：2007-11-02
申请人： Kosol Jintaseranee , Qiu Jin , Travis E. Dawson , Jing Jong Yea , John N. Larson , Linda Chau
发明人： Kosol Jintaseranee , Qiu Jin , Travis E. Dawson , Jing Jong Yea , John N. Larson , Linda Chau
IPC分类号： H04W4/00
CPC分类号： H04W60/00 , H04W80/04
摘要： A method and apparatus for processing mobile-IP registration messages. Upon receipt of a mobile-IP registration request (RRQ) message that designates a care-of address matching the mobile-IP home agent's IP address, the RRQ would be dropped. Alternatively, before deciding to drop such an RRQ, the invention may further involve determining whether the home agent is currently functioning as a foreign agent for the requesting mobile node, which would justify the care-of address matching the home agent's IP address. If the home agent is not currently functioning as a foreign agent for the mobile node, then the RRQ would be dropped. On the other hand, if the home agent is currently functioning as a foreign agent for the mobile node, then RRQ processing would proceed as normal.
摘要翻译：一种用于处理移动IP注册消息的方法和装置。在接收到指定与移动IP归属代理的IP地址匹配的转交地址的移动IP注册请求（RRQ）消息时，RRQ将被丢弃。或者，在决定丢弃这样的RRQ之前，本发明可以进一步包括确定归属代理当前是否用作请求移动节点的外部代理，这将证明与归属代理的IP地址匹配的转交地址。如果归属代理当前不作为移动节点的外部代理，则RRQ将被丢弃。另一方面，如果归属代理当前用作移动节点的外部代理，则RRQ处理将正常进行。

2. 发明申请

US20130316312A1 Apparatus for Displaying Braille on an Attachable Device and Method Thereof 审中-公开
标题翻译：用于在可附接装置上显示盲文的装置及其方法
公开(公告)号：US20130316312A1
公开(公告)日：2013-11-28
申请号：US13478021
申请日：2012-05-22
申请人： Joy Qiu Jin
发明人： Joy Qiu Jin
IPC分类号： G09B21/02
CPC分类号： G09B21/003
摘要： The present invention includes a flat face, a dots raising mechanism, a display cell, a first column, a second column, an interface, and a connection port. The first column includes a first dot, second dot, and a third dot while the second column includes a fourth dot, a fifth dot, and a sixth dot. The columns are on the display cell. The display cell is capable of displaying a single Braille character. To convey information from a text source, the display cell raises and lowers the dots, successively forming different characters. A first time interval, a second time interval, and a third time interval help differentiate the first column from the second column, a first character from a following character, and a first word from a following word. The time intervals simulate physical space between and with the cells found in printed Braille.
摘要翻译：本发明包括平面，点提机构，显示单元，第一列，第二列，接口和连接端口。第一列包括第一点，第二点和第三点，而第二列包括第四点，第五点和第六点。列在显示单元格上。显示单元能够显示单个盲文字符。为了从文本源传送信息，显示单元提高并降低点数，连续地形成不同的字符。第一时间间隔，第二时间间隔和第三时间间隔有助于区分第一列与第二列，来自后续字符的第一个字符和来自后续字的第一个字。时间间隔模拟印刷盲文中发现的细胞之间的物理空间。

3. 发明授权

US08084621B2 3-Pyrrolo[b]cyclohexylene-2-dihydroindolinone derivatives and uses thereof 有权
标题翻译： 3-吡咯并[b]环己基-2-二氢吲哚啉酮衍生物及其用途
公开(公告)号：US08084621B2
公开(公告)日：2011-12-27
申请号：US12517351
申请日：2007-12-03
申请人： Feng Tang , Han Shen , Qiu Jin , Lei Ding , Jie Yang , Xiaojin Yin , Shiyue Lu
发明人： Feng Tang , Han Shen , Qiu Jin , Lei Ding , Jie Yang , Xiaojin Yin , Shiyue Lu
IPC分类号： C07D209/02 , A61K31/40
CPC分类号： C07D209/42 , C07D401/14 , C07D403/14
摘要： 3-pyrrolo[b]cyclohexylene-2-dihydro-indolinone derivatives of formula (I) or their pharmaceutically acceptable salts and uses thereof. The intermediates of formula (II) for preparing the above compounds. The bioassay shows that the above compounds and their pharmaceutically acceptable salts can modulate the activity of protein kinases (PKs), inhibit the activity of tyrosine kinases (PTKs) and inhibit many kinds of tumor cells as well as.
摘要翻译：式（I）的3-吡咯并[b]亚环己基-2-二氢 - 二氢吲哚酮衍生物或其药学上可接受的盐和用途。用于制备上述化合物的式（II）的中间体。生物测定显示，上述化合物及其药学上可接受的盐可调节蛋白激酶（PK）的活性，抑制酪氨酸激酶（PTK）的活性并抑制多种肿瘤细胞。

4. 发明申请

US20100160318A1 3-Pyrrolo[b]Cyclohexylene-2-Dihydroindolinone Derivatives and Uses Thereof 有权
标题翻译： 3-吡咯并[b]环己基-2-二氢吲哚啉酮衍生物及其用途
公开(公告)号：US20100160318A1
公开(公告)日：2010-06-24
申请号：US12517351
申请日：2007-12-03
申请人： Feng Tang , Han Shen , Qiu Jin , Lei Ding , Jie Yang , Xiaojin Yin , Shiyue Lu
发明人： Feng Tang , Han Shen , Qiu Jin , Lei Ding , Jie Yang , Xiaojin Yin , Shiyue Lu
IPC分类号： A61K31/404 , C07D209/42 , C07D413/12 , C07D401/12 , C07D403/12 , C07D405/08 , A61K31/5377 , A61K31/496 , A61K31/454 , A61K31/4439 , C07D401/14 , C07D403/14 , A61K31/4545 , A61P35/00 , A61P17/00 , A61P9/00 , A61P9/10 , A61P3/10 , A61P19/02 , A61P37/00 , A61P29/00 , A61P27/02
CPC分类号： C07D209/42 , C07D401/14 , C07D403/14
摘要： 3-pyrrolo[b]cyclohexylene-2-dihydro-indolinone derivatives of formula (I) or their pharmaceutically acceptable salts and uses thereof. The intermediates of formula (II) for preparing the above compounds. The bioassay shows that the above compounds and their pharmaceutically acceptable salts can modulate the activity of protein kinases (PKs), inhibit the activity of tyrosine kinases (PTKs) and inhibit many kinds of tumor cells as well as.
摘要翻译：式（I）的3-吡咯并[b]亚环己基-2-二氢 - 二氢吲哚酮衍生物或其药学上可接受的盐和用途。用于制备上述化合物的式（II）的中间体。生物测定显示，上述化合物及其药学上可接受的盐可调节蛋白激酶（PK）的活性，抑制酪氨酸激酶（PTK）的活性并抑制多种肿瘤细胞。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式